Skin Graft Market Size, Share, and Industry Analysis By Type (Allograft, Xenograft, and Synthetic Skin Substitutes), By Graft Thickness (Split-thickness Graft, Full-thickness Graft, and Composite Grafts), By Application (Surgical Wounds, Burns, Diabetic Ulcers, Reconstructive Surgery, and Others), By End-user (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2024-2032

Skin graft is a surgical procedure where skin is taken from one area of the body and transplanted to another area of the body. Skin grafting procedures are typically performed to treat lost skin due to burns, injuries, or illnesses. The grafts facilitate healing and restore skin function in areas that have been damaged or lost.

The market for skin grafts is expected to grow due to factors such as the increasing prevalence of chronic wounds, skin-related disorders and diseases, and a rising number of surgical procedures. Moreover, advancements in medical technology and the growing demand for cosmetic surgeries are expected to drive market growth during the forecast period. The market is also driven by the rising number of accidents, burns, and other traumatic injuries that require skin grafts for reconstruction and healing.

• For instance, according to an article published in Advances in Wound Care in March 2021, in the U.S. around 2.0% of the total population is estimated to have chronic wounds.

Furthermore, increasing awareness about the benefits of skin grafts and the improving healthcare infrastructure in developing countries are also contributing to the market growth. Additionally, advancements in skin graft technology and advanced product launches are likely to drive industry growth.

Skin grafts are also required in skin cancer surgeries to repair defects caused by the removal of cancerous skin. The increasing number of skin cancer surgeries and the rising incidence of chronic wounds in aging population will also continue to support the demand for skin graft procedures and products in the foreseeable future.

The skin graft market witnessed a decline in growth at the beginning of the COVID-19 pandemic. The worldwide lockdowns reduced elective surgical procedures in hospitals, clinics, and ambulatory surgical centers. It impacted the performance of the market in 2020, resulting in a decline in growth.

• For instance, according to an article published by Division of Plastic Surgery, King Saud University, the frequency of admissions to plastic surgery, including skin grafting, was reduced by 47% in 2020 compared to 2019.

The relaxation of the lockdown in 2021 increased skin grafting procedures due to the resurgence of patient visits to clinics and hospitals. This growth in surgical volume increased the demand for skin grafts in the near future.

Key Insights

The report covers the following key insights:

• Prevalence of Key Diseases, By Key Countries/ Region, 2023


• New Product Launches, by Key Players


• Key Industry Developments - Mergers, Acquisitions, and Partnerships


• Impact of COVID-19 on the Market

Segmentation

Analysis by Type

Based on type, the market is segmented into allograft, xenograft, and synthetic skin substitutes. The allograft segment generated significant share in market. The rising number of skin grafting procedures and the wide availability of allografts are the key factors expected to drive the segment growth. Additionally, dermatology and plastic surgery advancements have ensured more effective and safer allografting procedures, further contributing to the segment growth.

The synthetic skin substitutes segment is anticipated to grow rapidly over projected years. Increase in the introduction of novel skin substitutes and increasing R&D initiatives for the development of engineered skin and a rising number of mergers and acquisitions are the major factors anticipated to drive the segment growth.

• For instance, in April 2021, MedSkin Solutions launched MariGen Shield skin graft which combines silicone with its fish-skin graft to treat chronic and complex wounds. The product was launched in 20mm and 30mm sizes specifically for the application to chronic foot wounds.

Regional Analysis

North America is expected to lead the market with a significant revenue share and will dominate the market over projected years. The region's significant growth is mainly attributed to the increasing number of patients suffering from chronic wounds and the expanding number of skin cancer surgeries. Furthermore, the presence of major market players committed to strategic initiatives such as engaging in mergers and acquisitions and launching innovative products is expected to contribute to the region's growth in the skin graft market.

• For instance, in December 2021, Paragon 28, Inc. launched ParaDerm, a non-fenestrated dermal matrix, designed to facilitate cellular infiltration, attachment, and proliferation for healing.

Asia Pacific region is anticipated to grow rapidly during the forecast period. This is driven by the rising prevalence of chronic wounds mediated by diabetes, increasing incidence of burn injuries and skin disorders, and growing demand for aesthetic procedures. The market is also likely to be influenced by growth in the demand for aesthetic procedures in the region.

Key Players Covered

The report includes the profiles of key players such as AlloSource, Stryker, INTEGRA LIFESCIENCES, Rudolf Storz GmbH, Smith+Nephew, and Coloplast Corp.

Key Industry Developments

• In July 2023, Coloplast Corp acquired Kerecis, an Iceland-based company that developed technology that uses fish skin as skin graft substitutes to perform transplantation.


• In October 2021, AlloSource launched the AlloMend Extra-Large (XL) Acellular Dermal Matrix (ADM), the newest addition to the AlloMend product line. The introduction of this product would help expand its dermal graft portfolio.


• In April 2021, MedSkin Solutions launched MatriDerm, a single-use, three-dimensional acellular dermal composed of bovine elastin & collagen fibers. The product was launched in four sizes to be used in split-thickness skin graft procedures.